We’re excited to announce that Dr. Art Hsing-Mao Chu, CEO of T-E PHARMA, will be presenting at the Investment Summit Session of BIO Asia–Taiwan 2026 conference.
Time: 16:15-17:20 Roadshow, Wednesday, July 15, 2026
Venue: Room 701AB, 7F, TaiNEX2
Dr. Chu will present the latest R&D progress across our pipeline, including the most recent clinical progress of our two clinical-stage drug candidates, TE-8105 and TE-8214. The event also provides an excellent opportunity to connect with biotechnology industry leaders, investors, and potential partners to explore strategic collaborations that advance innovative drug development, accelerate commercialization, and ultimately improve patient care.
If you’re attending, we’d love to connect and explore how we can innovate together!
